AzTrials
AzTrials

Postsurgical Pain ManagementPhase 3TPS-SelectNCT07296770

An Artificial Intelligence Driven Approach to Optimize Patient Selection for a Transitional Pain Service

A Phase 3 study testing TPS-Select, Pharmacologic Pain Management and Interventional Pain Procedures in people with Postsurgical Pain Management and Postsurgical Pain, Chronic, run by University of California, San Francisco at 1 site in United States.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this clinical trial is to learn whether a pain-management program called a Transitional Pain Service can help prevent long-term pain and reduce opioid needs after surgery in adult surgical patients who may be at higher risk for developing persistent pain. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
TPS-Select, Pharmacologic Pain Management and Interventional Pain Procedures
Could I receive a placebo?
No, everyone receives an active treatment
How many people
474 participants
Where
1 siteUnited States
Study dates
1 Oct 2026to 1 Dec 2029
Phase
Phase 3
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Patients may take part in this study if they:

  • Are 18 years or older
  • Are having a planned (elective) surgery at UCSF
  • Are identified as higher risk for chronic pain after surgery by a computer model
  • Agree to join the study and sign consent

Patients cannot take part if they:

  • Have too much missing information in their medical record (more than 75%)
  • Have a surgery scheduled less than 21 days away
  • Have serious memory or thinking problems that make participation difficult
  • Are in another clinical study that would interfere with this one
  • Do not live in California
  • Choose not to participate or sign consent
  • Have severe depression with suicidal thoughts that requires urgent care
  • Are pregnant or breastfeeding

A patient who has already joined may be removed from the study if they:

  • Cannot complete most of the scheduled follow-up phone calls or pre-surgery recommendations (up to 6 months after discharge)
  • Pass away between the surgery booking date and 6 months after leaving the hospital
  • Become pregnant in the 6 months after discharge

Patients may remain enrolled but their data may not be used in the main study results if they experience:

  • A long-lasting infection after surgery
  • Hardware problems related to their surgery (for example, issues with implanted devices)
  • A major injury or life event that affects their pain levels, such as a significant fall or an emergency surgery
  • Difficulty completing the planned follow-up phone calls up to 6 months after discharge

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Akash Shanmugam, BS contact

408-242-3095

akash.shanmugam@ucsf.edu

Madeline Holt, BS contact

978-317-9071

madeline.holt@ucsf.edu

United States1 site
  • UCSF Hospitals

    San Francisco, California, 94131

    Andrew Bishara, MD, 419-266-4764, andrew.bishara@ucsf.edu

Other trials in United States

About this study

The goal of this clinical trial is to learn whether a pain-management program called a Transitional Pain Service can help prevent long-term pain and reduce opioid needs after surgery in adult surgical patients who may be at higher risk for developing persistent pain. The main questions this trial aims to answer are: 1) Does the Transitional Pain Service help high-risk surgical patients manage pain better after surgery? 2) Can a computer tool (an algorithm) improve screening of patients for long-lasting pain after surgery? The investigators will compare patients who continue with their usual care to patients who receive support from the Transitional Pain Service to see if the program leads to better pain control and lower opioid use. Participants will share information about their pain levels and the pain-relief treatments they are using before and after surgery so researchers can better understand how the program affects recovery. Patients assigned to the Transitional Pain Service will also be offered additional coordinated support before and after their surgery to help optimize their pain control and overall recovery.

Being tested
TPS-Select, Pharmacologic Pain Management, Interventional Pain Procedures, Psychological Management and Pain Education, Physical Therapy
Keywords
Pain, Transitional Pain Service, Postsurgical Pain, Postoperative Opioid Use
Medical subject headings
Pain, Postoperative, Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • TPS-SelectDevice

    TPS-Select is a computer-based tool that helps the research team identify patients who may be eligible for this study. It uses information that already exists in the medical record at the time a surgery is scheduled to estimate the chance of developing ongoing pain after surgery. This information can include details about the planned surgery, prior medical conditions, past surgeries, and previous use of pain medications.

    The tool runs automatically and is used only to help the research team decide whom to contact about possible participation in the study. The risk estimate created by this tool is not added to the medical record and is not seen by the patient's care team. Only approved members of the research team can see this information through a secure research system.

  • Pharmacologic Pain ManagementDrug

    Also called Oxycodone Hydrochloride, Hydrocodone Bitartrate and Acetaminophen, Morphine Sulfate, Methadone Hydrochloride

    A pharmacist will meet with patients as part of the Transitional Pain Service before and after surgery. During this visit, the pharmacist will work with patients to create a personalized pain management plan, using the medications stated in this intervention to help safely and effectively control pain. This will guide patients on the proper use of opioid analgesics and non-opioid analgesics, including acetaminophen, non-steroid anti-inflammatory drugs, gabapentinoids, and topical medications to manage surgical pain.

  • Interventional Pain ProceduresProcedure or surgery

    Also called Epidural Steroid Injection, Acupuncture, Trigger Point Injection, Peripheral Nerve Block

    If a patient has significant pain after their surgery, the care team may evaluate the patient for additional pain-relief options, such as the interventional pain procedures listed above. Local numbing medication or imaging studies may also be used to ensure the treatment is safe and appropriate. All anesthesiologists on the pain service are specially trained to perform these procedures. Only approved procedures will be offered, along with any imaging needed for evaluation.

  • Psychological Management and Pain EducationBehavioural

    Patients will be asked to complete short online pain education modules to help set expectations and prepare for pain after surgery. These materials are available at https://www.transitionalpainservice.ca/learn. Each patient will also be screened for mood-related concerns, including symptoms of depression, using a brief questionnaire. If a patient has significant symptoms of depression, they may be referred to a pain psychologist and, if needed, a UCSF psychiatrist for additional support. These visits may include proven approaches such as cognitive behavioral therapy, acceptance and commitment therapy, and mindfulness-based strategies to help patients manage pain, cope with stress, and improve daily functioning. Patients with milder symptoms may be referred to group-based pain psychology sessions led by a pain psychologist.

  • Physical TherapyBehavioural

    Patients will be assessed for their physical function and ability to carry out daily activities. If a patient has difficulty with mobility, strength, or endurance, they may be referred to physical or occupational therapy before surgery to help improve overall conditioning. Pre-surgery therapy may include exercises to strengthen the core, arms, and legs, improve balance, and build stamina, as well as an overall fitness assessment. Referrals will only be made if it is safe for the patient to participate, and standard safety checks-such as heart health and fall risk-will be completed beforehand. All therapy will be provided by a licensed physical therapist using established, evidence-based treatment plans.

Study groups in NCT07296770
Study groupRoleWhat they receive
Transitional Pain ServiceExperimentalPatients assigned to the Transitional Pain Service group will receive extra support before and after surgery to help with pain and recovery. This may include educational videos, meetings with a pain pharmacist for safe medication use and tapering, mental health screening with referrals to supportive resources, and physical therapy. Patients may also be offered pain-relief procedures or treatments such as nerve blocks, injections, imaging, or other outpatient therapies provided by pain specialists. These services are meant to support recovery, and patients may choose how much to participate while remaining in the study even if all activities are not completed.
Receives: Device: TPS-Select; Drug: Pharmacologic Pain Management; Procedure: Interventional Pain Procedures; Behavioral: Psychological Management and Pain Education; Behavioral: Physical Therapy
Usual CareNo interventionIn this arm, patients will receive usual surgical care. However, patients will still complete the questionnaires to measure their pain, opioid use, and recovery.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Presence of Chronic Post-Surgical Pain

    This outcome measures how many patients in each group (Standard of Care vs. Transitional Pain Service) have chronic post-surgical pain 90 days after date of surgery. Chronic post-surgical pain refers to worsening pain in a preoperative pain region or the development of pain in a new region.

    Measured: 90 days after date of surgery

Secondary outcomes (4)
  1. Opioid Use After Surgery

    This measures the amount of opioid medication patients are using after surgery, recorded as morphine milligram equivalents (MMEs). Average MMEs will be compared between groups to see whether the program helps reduce opioid needs.

    Measured: 30, 90, and 180 days after discharge from hospital

  2. Pain Levels After Surgery

    This outcome looks at patients' reported pain magnitude and pain interference scores over time. The study will compare average pain levels between the two groups to understand how the program affects recovery.

    Measured: 30, 90, and 180 days after discharge from the hospital

  3. Healthcare Costs

    This measures costs to the hospital related to pain care and recovery after surgery. Average costs will be compared between groups to evaluate whether the Transitional Pain Service may reduce overall costs.

    Measured: 30, 90, and 180 days after discharge from the hospital

  4. Pain in Surgical Region

    This outcome mreasures patient-reported presence of pain localized to the surgical site.

    Measured: 30 Days, 90 Days, 180 Days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Dec 2025
  2. Study start1 Oct 2026 (estimated)
  3. Primary completion1 Dec 2028 (estimated)
  4. Study completion1 Dec 2029 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 3
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
After a patient joins the study, they will be randomly assigned to either the standard care group or the Transitional Pain Service (TPS) group. The assignment will be done by the study coordinator using a process that helps keep the groups balanced by sex. All patients in the study are considered high-risk.
Masking
None (open label)
Enrolment
474 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07296770
Sponsor's protocol ID
24-42631
Acronym
TPS-Select
Status last verified
Oct 2026
First submitted
18 Dec 2025
Last updated
9 Oct 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
Yes
FDA-regulated device
Yes
Individual data sharing
No: Individual participant data will not be shared with outside researchers because the information collected in this study includes sensitive health details that could pose privacy risks if shared. Although all data are protected and stored securely, sharing IPD outside the study team may increase the chance of re-identification. To protect patient privacy, only summarized results that do not identify any individual will be shared publicly.

Questions about this trial

What is this clinical trial studying?

A Phase 3 study testing TPS-Select, Pharmacologic Pain Management and Interventional Pain Procedures in people with Postsurgical Pain Management and Postsurgical Pain, Chronic, run by University of California, San Francisco at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 9 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 3 studies compare the treatment with the current standard treatment or a placebo in a large group, to confirm how well it works and watch for side effects.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Akash Shanmugam, BS (408-242-3095, akash.shanmugam@ucsf.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Presence of Chronic Post-Surgical Pain (time frame: 90 days after date of surgery). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in